Literature DB >> 7848092

Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis.

S T Fan1, E C Lai, C M Lo, I O Ng, J Wong.   

Abstract

OBJECTIVE: To define the safety of major hepatectomy for hepatocellular carcinoma (HCC) associated with cirrhosis and the selection criteria for surgery in terms of hospital mortality.
DESIGN: Major hepatectomy for HCC in the presence of cirrhosis is considered to be contraindicated by many surgeons because the reported mortality rate is high (26% to 50%). Previous workers recommended that only selected patients with Child's A status or indocyanine green (ICG) retention at 15 minutes of less than 10% undergo major hepatectomy. A survey was made, therefore, of our patients with HCC and cirrhosis undergoing major hepatectomy between 1989 and 1994.
SETTING: A tertiary referral center. PATIENTS: The preoperative, intraoperative, and postoperative data of 54 patients with cirrhosis who had major hepatectomy were compared with those of 25 patients with underlying chronic active hepatitis and 22 patients with normal livers undergoing major hepatectomy for HCC. The data had been prospectively collected. INTERVENTION: Major hepatectomy, defined as resection of two or more liver segments by Goldsmith and Woodburn nomenclature, was performed on all the patients. MAIN OUTCOME MEASURE: Hospital mortality, which was defined as death within the same hospital admission for the hepatectomy.
RESULTS: Preoperative liver function in patients with cirrhosis was worse than in those with normal livers. The intraoperative blood loss was also higher (P = .01), but for patients with cirrhosis, chronic active hepatitis, and normal livers, the hospital mortality rates (13%, 16%, and 14%, respectively) were similar. The hospital mortality rate for patients with cirrhosis in the last 2 years of the study was only 5%. Patients with cirrhosis could tolerate up to 10 L of blood loss and survive the major hepatectomy. By discriminant analysis, an ICG retention of 14% at 15 minutes was the cutoff level that could maximally separate the patients with cirrhosis with and without mortality.
CONCLUSION: Major hepatectomy for HCC in the presence of cirrhosis is associated with a mortality rate that is not different from the rate for patients with normal livers. An ICG retention of 14% at 15 minutes would serve as a better selection criterion than the 10% previously used.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7848092     DOI: 10.1001/archsurg.1995.01430020088017

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  93 in total

1.  Comparative study of perioperative management of hepatic resection.

Authors:  K Akashi; S Mizuno; S Isaji
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

2.  Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?

Authors:  Ronnie Tung Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Kei Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

3.  Plastic iodophor drape during liver surgery operative use of the iodophor-impregnated adhesive drape to prevent wound infection during high risk surgery.

Authors:  Yasuko Yoshimura; Shoji Kubo; Kazuhiro Hirohashi; Masao Ogawa; Ken Morimoto; Kumiko Shirata; Hiroaki Kinoshita
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

4.  The effect of surgical volume and the provision of residency and fellowship training on complications of major hepatic resection.

Authors:  Geoffrey Paul Kohn; Mehrdad Nikfarjam
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

5.  Technical refinement in adult-to-adult living donor liver transplantation using right lobe graft.

Authors:  S T Fan; C M Lo; C L Liu
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

6.  Liver Resection for De Novo Hepatocellular Carcinoma Complicated by Pyogenic Liver Abscess: A Clinical Challenge.

Authors:  Kenneth S H Chok; Tan To Cheung; Albert C Y Chan; Wing Chiu Dai; See Ching Chan; Chung Mau Lo
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

7.  Risk factors for postoperative delirium after liver resection for hepatocellular carcinoma.

Authors:  Yasuko Yoshimura; Shoji Kubo; Kumiko Shirata; Kazuhiro Hirohashi; Hiromu Tanaka; Taichi Shuto; Shigekazu Takemura; Hiroaki Kinoshita
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

8.  Preliminary experience in adult-to-adult living donor liver transplantation in a single center in China.

Authors:  Lunan Yan; Bo Li; Yong Zeng; Tianfu Wen; Jichun Zhao; Wentao Wang; Jiayin Yang; Mingqing Xu; Yukui Ma; Zheyu Chen; Jiangwen Liu; Hong Wu
Journal:  Front Med China       Date:  2007-02-01

9.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

10.  Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database.

Authors:  Ronnie T Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Key Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.